Used as a key intermediate in the synthesis of pharmaceutical agents targeting central nervous system disorders. Shows potential in the development of compounds with antipsychotic and dopaminergic activity. Commonly employed in research settings to explore treatments for neurological conditions such as schizophrenia and Parkinson’s disease. Its structure allows for selective modification to enhance binding affinity to dopamine receptors, making it valuable in medicinal chemistry for designing novel therapeutics.